Results 151 to 160 of about 1,064,547 (319)
FEBS Letters, EarlyView.We identified a systemic, progressive loss of protein S‐glutathionylation—detected by nonreducing western blotting—alongside dysregulation of glutathione‐cycle enzymes in both neuronal and peripheral tissues of Taiwanese SMA mice. These alterations were partially rescued by SMN antisense oligonucleotide therapy, revealing persistent redox imbalance as ...
Sofia Vrettou, Brunhilde Wirth
wiley +1 more source
, 2003 Therapeutics Letter 49 discusses optimal dosing strategies for statins for secondary prevention. Conclusions: Statins provide a cardiovascular and total mortality benefit for patients with clinically evident occlusive vascular disease (secondary ...
Therapeutics Initiative (University of British Columbia)
core
FEBS Letters, EarlyView.In this study, we found that human cervical‐derived adipocytes maintain intracellular iron level by regulating the expression of iron transport‐related proteins during adrenergic stimulation. Melanotransferrin is predicted to interact with transferrin receptor 1 based on in silico analysis.
Rahaf Alrifai +9 more
wiley +1 more source
, 1999 Therapeutics Letter 32 reviews the management of erectile dysfunction. Conclusions: Inquire about erectile dysfunction in all adult males as a potential early indicator of modifiable factors.
Therapeutics Initiative (University of British Columbia)
core
FEBS Letters, EarlyView.Structural and biochemical characterisations show that the planar cell polarity (PCP) protein Inturned harbours a unique PDZ‐like domain that does not bind canonical PDZ‐binding motifs (PBMs) like that of another PCP protein Vangl2. In contrast, the apical‐basal polarity protein Scribble contains four PDZ domains that bind Vangl2, but one PDZ domain ...
Stephan Wilmes +4 more
wiley +1 more source
, 2013 Therapeutics Letter 88 explores the use of pragmatic randomized trials as a means of addressing gaps in evidence. Compared to efficacy trials, pragmatic (effectiveness) trials are intended to answer the questions that clinicians and patients have ...
Therapeutics Initiative (University of British Columbia)
core
Calpain small subunit homodimerization is robust and calcium‐independent
FEBS Letters, EarlyView.Calpains dimerize via penta‐EF‐hand (PEF) domains. Using single‐molecule force spectroscopy, we measured the strength and kinetics of PEF–PEF homodimer binding. The interaction is robust, shows a transient conformational step before dissociation, and remains largely insensitive to Ca2+.
Nesha May O. Andoy +4 more
wiley +1 more source
, 1994 Therapeutics Letter 3 discusses treatment of gastroesophageal reflux disease (GERD). GERD symptoms should be treated with antacids or H2-blockers as much as possible. In refractory cases omeprazole is effective.
Therapeutics Initiative (University of British Columbia)
core
Structural insights into an engineered feruloyl esterase with improved MHET degrading properties
FEBS Letters, EarlyView.A feruloyl esterase was engineered to mimic key features of MHETase, enhancing the degradation of PET oligomers. Structural and computational analysis reveal how a point mutation stabilizes the active site and reshapes the binding cleft, expading substrate scope.
Panagiota Karampa +5 more
wiley +1 more source